THE LONG VIEW

The research journal.

Company research on Celsius Holdings, Inc. (CELH), including the business, investment thesis, risks, and valuation.

CELH · Research: 2026-10-21 (comparison refresh; fundamental review preserved from 2026-10-04)
CELH NASDAQ · Consumer Staples / Non-Alcoholic Beverages

Celsius Holdings, Inc.

HoldMedium-High risk · 60/100 valuation confidence

Price snapshot: 2026-11-03 · Research: 2026-10-21 (comparison refresh; fundamental review preserved from 2026-10-04) · Saved analysis, not live market data

Ratings and fair values are independent, dated research opinions—not personalized investment advice. Disclaimer

Reference price$29.982026-11-03
Weighted fair value$36.80Probability-weighted model
Return to fair value+22.7%Not an annualized return
Business quality76.1/100Tier Tier B · price independent

What is the price assuming?

USD per share

The reference price is below the probability-weighted fair value.

Dashed marker: reference price $29.98. Scenario values are present fair values, not dated price targets.

See the assumptions behind each scenario

Bear · 30%

CELSIUS remains weak; Alani slows; margins remain high-40s

Material risk that core-brand weakness is more structural and portfolio synergies take longer

Base · 50%

CELSIUS returns to modest growth; Alani remains strong; gross margin approaches ~50%+

Most likely if 2026 disruption proves temporary but recovery is gradual

Bull · 20%

CELSIUS recovery + Alani durability + international contribution + margin normalization

Requires cleaner execution and faster proof of portfolio leverage
Strong Buy zone≤ $23.76
Buy zone> $23.76–$29.44
Avoid above> $40.89

FolioFacts zones calculated from the saved fair and bear values at the dated reference price. Live zones can change with research.

The business behind the valuation.

CELH has evolved from a fast-growing single-brand company into a three-brand energy platform:

Business drivers

  • Business durability and economics. Attractive energy category, strong cash generation and multi-brand portfolio, offset by volatile consumer demand and promotion
  • Moat and competitive position. Brand equity, PepsiCo distribution and retailer scale; limited switching costs and stronger leaders in Red Bull/Monster
  • Growth runway and durability. Alani Nu, category expansion, international whitespace and broader portfolio

What could weaken the thesis

  • CELSIUS brand. Remains meaningfully negative through H1 2027 despite restored innovation and distribution
  • Alani Nu. Sharp growth deceleration, weak repeat behavior or heavy LTO dependence
  • Gross margin. Remains below roughly 48%-49% despite normalization

The financial picture.

USD millions

Revenue

Reported FY totals, current FY quarters and cumulative YTD are grouped separately.

Completed fiscal years

Scale within group: $2,600M

FY2023
$1,320M
FY2024
$1,360M
FY2025
$2,520M

Current fiscal year · standalone quarters

Scale within group: $860M

Q1 FY2026
$782.62M
Q2 FY2026
$817.93M
Q3 FY2026
$847.23M

Current fiscal year · cumulative YTD

Scale within group: $2,600M

H1 FY2026
$1,600.54M
9M FY2026
$2,447.77M

Cash flow vs. stock-based compensation

Completed FY, standalone current-year quarters and cumulative YTD. No TTM figures.

Free cash flowStock-based compensation

Completed fiscal years

Each row covers a completed fiscal year. Scale within this group: $340M.

FY2023
$124M
$21M
SBC / FCF 16.9%
FY2024
$240M
$20M
SBC / FCF 8.3%
FY2025
$323M
$28M
SBC / FCF 8.7%

Current fiscal year · standalone quarters

Each row covers an independent quarter; derived cash flow is labeled. Scale within this group: $220M.

Q1 FY2026FCF calculated
$65.81M
$7.63M
SBC / FCF 11.6%
Q2 FY2026FCF calculated
$205.48M
$10.57M
SBC / FCF 5.1%
Q3 FY2026FCF calculated
$127.69M
$8.71M
SBC / FCF 6.8%

Current fiscal year · cumulative YTD

YTD totals overlap the quarters above and must not be added to them. Scale within this group: $400M.

H1 FY2026FCF calculated
$271.28M
$18.19M
SBC / FCF 6.7%
9M FY2026FCF calculated
$398.98M
$26.91M
SBC / FCF 6.7%

Each annual, quarter and YTD group uses a separate scale. SBC / FCF is a same-period comparison, not a literal employee cash payment. N/M means FCF is zero or negative (or SBC is negative); missing is not zero. Issuer FCF definitions may vary.

Latest period 9M FY2026Operating margin 15.8%Cash $700.62M

Only completed fiscal years and currently open fiscal-year quarters/YTD appear in charts. Standalone quarters and cumulative YTD are separate; missing is never zero. Legacy TTM rows remain in archival source text. The full financial profile below preserves definitions, accounting caveats, and period-end balance details.

How the business scores.

Quality / 100
Business durability and economics25% weight
76
Moat and competitive position25% weight
73
Growth runway and durability20% weight
84
Financial quality and balance sheet15% weight
78
Management, governance and capital allocation15% weight
69
Opportunity score at research price69.7/100

This score uses the saved price and research fundamentals. Creator Watchlist calculates the current score and rank using verified market prices.

What would change the view?

Watch the evidence behind the thesis, not just the ticker.

01CELSIUS brand

Would support the thesis

Returns to positive retail and net-revenue growth with productive shelf gains

Would weaken the thesis

Remains meaningfully negative through H1 2027 despite restored innovation and distribution

Affects: Thesis, Quality Score and base/bull valuation lower
02Alani Nu

Would support the thesis

Sustains strong core velocity as DSD comparisons normalize

Would weaken the thesis

Sharp growth deceleration, weak repeat behavior or heavy LTO dependence

Affects: Growth runway and valuation lower
03Gross margin

Would support the thesis

Recovers toward 50%-52% as integration, freight and RGM improve

Would weaken the thesis

Remains below roughly 48%-49% despite normalization

Affects: Earnings power and fair value lower
04PepsiCo execution

Would support the thesis

Better shelf/cold placement, service levels and revenue-growth management

Would weaken the thesis

Persistent service issues, unfavorable economics or incentive conflict

Affects: Moat and valuation confidence lower
05Rockstar

Would support the thesis

Stabilizes and improves velocity

Would weaken the thesis

Continued sustained decline or larger portfolio drag

Affects: Mostly removes optional upside unless drag expands
06International

Would support the thesis

CELSIUS and Alani establish repeatable growth in priority markets

Would weaken the thesis

Expansion remains immaterial or destroys margin

Affects: Long-term growth runway lower
07Leadership execution

Would support the thesis

Clear accountability and improved retail execution

Would weaken the thesis

Continued execution slippage or disruptive turnover

Affects: Management score and confidence lower
08Capital structure

Would support the thesis

Cash generation and repurchases offset dilution and dividend burden

Would weaken the thesis

Additional aggressive M&A, higher dilution or worsening preferred economics

Affects: Per-share value and management score lower

Go deeper, when you need to.

Investment Thesis

CELH has evolved from a fast-growing single-brand company into a three-brand energy platform:

Brand Role Q2 2026 Revenue Current Direction
CELSIUS Fitness, health and performance $387M -11.7% YoY revenue; retail sales -2%
Alani Nu Younger, female-skewed, flavor-led consumer $364M +21% reported revenue; retail +55.7%
Rockstar Traditional/core energy consumer $67M Retail sales -13%
Total Multi-brand portfolio $818M +10.6%

The headline 10.6% growth obscures a very different story underneath it. Alani Nu has become almost as large as CELSIUS and is doing the heavy lifting, while the original brand contracted sharply. Rockstar currently contributes scale but not growth.

The central investment question is whether CELSIUS's weakness is a temporary integration and assortment mistake inside an otherwise healthy brand or evidence that its competitive momentum has structurally weakened. I lean toward temporary but not yet proven. Management has acknowledged that it cut CELSIUS's assortment too aggressively and is rebuilding innovation and shelf presence for 2027, but it is describing the recovery as a gradual build rather than a quick rebound.

Long-term per-share value creation depends on four things: Alani Nu remaining durable, CELSIUS returning to growth, gross margin recovering toward the low-50% range, and the PepsiCo relationship creating more distribution value than the preferred-stock and concentration costs it introduces.

What the Market May Be Mispricing

The market may be underestimating three things.

First, Alani Nu increasingly looks like a second franchise rather than a purchased growth patch. Its Q2 retail sales increased 55.7%, and it held 8.7% of tracked U.S. RTD energy sales.

Second, PepsiCo gives CELH distribution capabilities that would be extremely difficult to recreate organically. The company can approach retailers with three differentiated brands rather than fighting for shelf space one product at a time.

Third, current earnings are being suppressed by integration, promotional intensity and gross-margin pressure. If consolidated growth remains healthy while gross margin recovers, earnings can grow faster than revenue.

The market is right to demand proof from the original CELSIUS brand. Alani Nu cannot indefinitely compensate for a structurally declining flagship.

The business and how it makes money

Celsius Holdings owns three major energy brands with distinct roles. The company develops, markets and sells functional beverages while relying heavily on PepsiCo for North American distribution. The model is relatively asset-light compared with a vertically integrated beverage manufacturer: brand strength, innovation, shelf and cold-space placement, retailer productivity, promotion efficiency and supply-chain execution matter more than owned production capacity.

Segment / Brand / Business Unit Role Revenue / Growth Economics / Position Strategic Takeaway
CELSIUS Fitness-first, zero-sugar functional energy $387M Q2 revenue; -11.7% YoY Largest legacy franchise; productivity per distribution point improved after SKU rationalization Recovery is the most important near-term thesis variable
Alani Nu Flavor-led modern energy with younger/female skew $364M Q2 revenue; +21% reported; retail +55.7% High consumer momentum and expanding distribution Genuine second growth franchise
Rockstar Traditional/core energy $67M Q2 revenue; retail -13% Integrated onto CELH platform; weak current growth Turnaround optionality, not required for base case
International CELSIUS-led expansion with future Alani opportunity $27M Q2 revenue; +10% YoY Small percentage of revenue today Long-duration upside rather than a 2027 valuation pillar

CELSIUS

CELSIUS is the original franchise and remains the foundation of the company. Its positioning around fitness, active lifestyles, zero sugar and functional energy differentiated it from traditional energy drinks and helped broaden the category toward health-conscious consumers.

Management rationalized SKUs while integrating Alani Nu and Rockstar, reducing CELSIUS points of distribution by roughly 7%. Dollars per point of distribution improved about 16% sequentially in Q2, suggesting the remaining assortment became more productive, but that productivity improvement did not offset lost assortment, greater promotional spending, club-channel softness and shipment timing.

Alani Nu

Alani Nu reaches a meaningfully different audience and has a stronger flavor and limited-time-offer culture than the original brand. CELH paid heavily for it, but Alani contributed roughly $1.0 billion of revenue in only nine months of CELH ownership during 2025 and continues to post strong consumer growth.

Rockstar

Rockstar gives CELH access to a traditional energy demographic that neither CELSIUS nor Alani targets as directly. Its current performance does not justify assigning meaningful turnaround value in the base case, which makes successful stabilization incremental upside rather than a required assumption.

Business Takeaway

CELH now makes money through a multi-brand energy platform rather than a single challenger brand. The most important long-term value drivers are CELSIUS brand recovery, Alani Nu durability, portfolio-level distribution productivity and margin normalization. Rockstar and international expansion can add upside, but neither is required to justify the current base case.

Industry and market context

Energy remains an attractive beverage category because consumer adoption is broadening beyond the traditional male energy-drink customer and into more usage occasions, wellness positioning and zero-sugar products. CELH's three-brand architecture is strategically aligned with that broadening market.

Management's Q2 presentation sizes the U.S. energy market at approximately $28.5 billion, with additional meaningful markets in Britain, Australia, France, Canada and other countries. International revenue remains a small portion of CELH today, so most international opportunity has not yet entered the financial base.

Market-Share Analysis

Company / Product / Segment Market Definition Current Share Prior Share Direction Investment Implication
Celsius Holdings portfolio U.S. RTD energy, Circana MULO+ w/C, Q2 2026 20.1% 21.0% Q1 2026 Down 0.9 ppt QoQ Still the clear #3 scaled portfolio, but sequential share softened
Red Bull U.S. RTD energy, Circana MULO+ w/C, Q2 2026 34.4% 34.6% Q1 2026 Down 0.2 ppt QoQ Category leader and most important direct operating competitor
Monster portfolio U.S. RTD energy, Circana MULO+ w/C, Q2 2026 32.2% 32.6% Q1 2026 Down 0.4 ppt QoQ Closest publicly traded direct operating and valuation comparable
CELSIUS brand U.S. RTD energy, Circana MULO+ w/C, Q2 2026 9.5% 9.9% Q1 2026 Down 0.4 ppt QoQ Core brand needs stabilization and renewed distribution
Alani Nu U.S. RTD energy, Circana MULO+ w/C, Q2 2026 8.7% 9.0% Q1 2026 Down 0.3 ppt QoQ Strong YoY retail growth remains the main portfolio growth engine
Rockstar U.S. RTD energy, Circana MULO+ w/C, Q2 2026 1.9% 2.0% Q1 2026 Down 0.1 ppt QoQ Turnaround remains unproven

The portfolio's long-term share gain has been substantial, but much of the jump versus early 2025 is acquisition-driven and should not be interpreted as organic share gain. The key next step is proving that the combined portfolio can grow share organically.

Industry Takeaway

The external market is large and attractive enough to support the thesis. TAM is not the binding constraint; execution is. CELH already has enough U.S. scale to matter materially to retailers and PepsiCo, so future value depends more on organic share productivity, brand health and international execution than on proving that the category is large enough.

Competition and the moat

Competitive Landscape

Competitor Market Share Positioning Advantages vs. Company Disadvantages vs. Company Current Direction
Red Bull 34.4% Q2 2026 U.S. RTD energy Global premium category leader Brand power, global reach, marketing machine, category leadership and consistency Less diversified modern-energy portfolio by consumer proposition Share down modestly QoQ but remains #1
Monster Beverage 32.2% Q2 2026 U.S. RTD energy portfolio Scaled global energy portfolio Scale, 55.9% Q2 gross margin, international reach, proven execution and public-market discipline CELH has stronger wellness positioning and faster-growing Alani Nu franchise Strong Q2 growth; remains #2
Emerging energy brands Not consistently comparable Trend-driven challengers such as Ghost, C4, Bloom and others Fast trend response, niche authenticity and focused communities Less portfolio scale, distribution leverage and retailer relevance than CELH Fragmented but strategically important

Moat Assessment

CELH does not have a traditional hard moat. Consumers can switch beverages instantly. Its defenses come from brand equity, shelf and cold-space access, PepsiCo distribution, retailer relevance, innovation cadence and scale.

The PepsiCo relationship is the biggest structural advantage. PepsiCo is the primary U.S./Canada distributor for the portfolio and has strategic economic and governance rights. That makes it difficult for smaller brands to match CELH's route-to-market, but the advantage has a real cost: PepsiCo's preferred securities have a combined $1.135 billion liquidation preference, pay a 5% cumulative dividend, and carry significant potential dilution and governance rights.

Moat direction: Stable, with potential to strengthen

Competitive Takeaway

CELH is structurally stronger than most emerging energy brands but remains behind Red Bull and Monster in proven global brand power, margins and operating consistency. Red Bull is the most important direct operating competitor; Monster is both a direct operating competitor and the closest public valuation comparable. CELH's differentiated advantage is its three-brand architecture and PepsiCo distribution, but that advantage only becomes durable if the flagship CELSIUS brand stabilizes.

Full financial profile and accounting context

Historical Financials

Financial reporting periods follow the issuer's fiscal year: completed FY rows plus standalone current-year quarters and cumulative H1/9M for FY2026. Revenue, FCF and SBC are flows; cash is a period-end balance. FCF = operating cash flow minus property/equipment capex from SEC company facts; quarterly FCF after Q1 and any quarterly SBC derived from YTD are visibly marked. Missing values are N/D, not zero. Unit: USD millions. Data extracted from SEC-tagged filings as of 2026-11-07. Company-specific FCF definitions and acquisition effects may require further reconciliation.

Period Revenue Growth Gross Margin Operating Margin FCF FCF Margin SBC Diluted Shares Cash Debt
FY2023 $1.32B — 48.0% 20.2% $124M 9.4% $21M 237.0M $756M $2M
FY2024 $1.36B 2.9% 50.2% 11.5% $240M 17.7% $20M 237.4M $890M $0M
FY2025 $2.52B 85.5% 50.4% 5.6% $323M 12.9% $28M 254.9M $399M $695M
Q1 FY2026 $782.615 N/D 48.3% 17.8% $65.807 (derived: CFO - capex) 8.4% $7.626 259.764 $549.201 N/D
Q2 FY2026 $817.925 N/D 48.1% 9.2% $205.477 (derived: current YTD - prior YTD) 25.1% $10.565 (derived: current YTD - prior YTD) 256.933 $631.234 N/D
H1 FY2026 $1,600.54 N/D 48.2% 13.4% $271.284 (derived: CFO - capex) 16.9% $18.191 258.495 $631.234 N/D
Q3 FY2026 $847.228 N/D 46.8% 20.3% $127.692 (derived: current YTD - prior YTD) 15.1% $8.714 (derived: current YTD - prior YTD) 254.912 $700.617 N/D
9M FY2026 $2,447.768 N/D 47.7% 15.8% $398.976 (derived: CFO - capex) 16.3% $26.905 257.269 $700.617 N/D

Supplemental historical reporting context (retained)

Supplemental historical reporting context (retained)

Supplemental historical reporting context (retained)

2025's enormous revenue growth was primarily acquisition-driven, while GAAP operating margin was distorted by large distributor-termination and integration-related costs. Free cash flow is more informative about the underlying economics: the business remains relatively capital-light and cash-generative.

Gross margin is the clearest near-term financial pressure point. Q2 gross margin fell to 48.1% from 51.5%. A return through 50% would create meaningful earnings leverage without requiring extraordinary top-line growth.

At June 30 CELH had roughly $631 million of cash and $675 million of debt, so conventional net debt is modest. That headline understates the economic capital burden because PepsiCo's preferred securities sit above common shareholders and generate roughly $57 million of annual preferred dividends at the current liquidation preference.

Financial Takeaways

  • Organic growth is materially weaker than headline consolidated growth because acquisitions and distribution transitions dominate the comparison.
  • Gross-margin recovery is a major source of potential earnings leverage.
  • Free cash flow remains a meaningful strength and supports integration, reinvestment and buybacks.
  • Conventional leverage is manageable, but preferred securities materially complicate the capital structure and potential dilution.
  • Per-share value creation depends on converting portfolio scale into organic growth and normalized margins rather than merely maintaining acquired revenue.

Financial direction: Mixed, but underlying cash economics remain healthy.

Valuation method and comparable companies

Current Valuation

Metric Value
Price Snapshot $29.98 — 2026-11-03 regular-session close, America/New_York
Market Capitalization ~$6.77B
Enterprise Value ~$6.81B
Forward P/E ~19.9×
Price / Sales ~2.2×
Price / FCF ~14.6×

At the current price, CELH has lost most of the premium historically attached to its growth story. The valuation now prices the company much closer to a normal consumer-growth business while still applying some premium to mature beverage companies.

Only the price row is refreshed here. Other quoted valuation statistics retain their earlier source dates and definitions.

Comparable Company Analysis

Company Relevance Public / Private Forward P/E Price / Sales Price / FCF Growth / Margin / Risk Context
Celsius Holdings Subject company Public 19.9× 2.2× 14.6× Q2 revenue +10.6%; 48.1% gross margin; higher integration and flagship-brand execution risk
Monster Beverage Primary direct operating and public valuation comparable Public 34.9× 9.1× 40.1× Q2 revenue +20.2%; 55.9% gross margin; much larger international scale and stronger operating consistency
Red Bull Primary direct operating comparable Private N/A — private N/A — private N/A — private 2025 group turnover €12.196B (+8.6%), 13.969B cans sold, 178-country presence; no public-market multiple
PepsiCo Secondary mature-beverage valuation and strategic-distribution anchor Public 14.5× 1.8× 18.5× Much more diversified, lower-growth and lower-risk; useful as a mature beverage floor, not a direct energy pure-play

Comparable takeaway: Red Bull and Monster are the economically relevant direct competitors. Monster is the only close publicly traded valuation comparable; Red Bull is private and therefore should remain visible with market multiples marked unavailable rather than being replaced by a less-relevant public company. PepsiCo is useful only as a secondary mature-beverage valuation anchor. A mechanical peer average across these companies would be misleading.

Valuation Scenarios

My primary framework uses normalized 2027 adjusted EPS because near-term GAAP earnings remain distorted by integration and distributor-related accounting.

Scenario Key Assumptions 2027 EPS Multiple Fair Value Probability Probability Rationale Return From Price Snapshot
Bear CELSIUS remains weak; Alani slows; margins remain high-40s $1.35 16× $21.60 30% Material risk that core-brand weakness is more structural and portfolio synergies take longer -28.0%
Base CELSIUS returns to modest growth; Alani remains strong; gross margin approaches ~50%+ $1.75 22× $38.50 50% Most likely if 2026 disruption proves temporary but recovery is gradual +28.4%
Bull CELSIUS recovery + Alani durability + international contribution + margin normalization $2.05 27× $55.35 20% Requires cleaner execution and faster proof of portfolio leverage +84.6%
Probability-Weighted 30% Bear / 50% Base / 20% Bull — — $36.80 100% Weighted scenario outcome +22.7%

The 22× base multiple represents a substantial discount to Monster while recognizing that CELH deserves more than a mature-beverage multiple if its portfolio can sustain growth. The bull case still uses a multiple materially below Monster's current valuation.

The bear case is what makes the current setup attractive. CELH does not need to regain its former premium valuation for $26.75 to work. Modeled downside is about 19% in the bear case, versus roughly 38% probability-weighted expected upside.

Valuation Takeaway

  • Primary valuation method: Normalized 2027 adjusted EPS scenario analysis
  • Cross-check methods: Forward P/E, price/sales, price/FCF and public-market comparison primarily against Monster, with PepsiCo as a secondary mature-beverage anchor
  • Key valuation dependencies: CELSIUS returning to growth, Alani Nu remaining durable, gross margin recovering and PepsiCo economics not becoming a larger drag
  • Valuation confidence / Risk Level: Medium-High risk with moderate valuation confidence
  • Margin-of-safety conclusion: The current price provides enough expected upside relative to modeled bear-case downside for a Buy; below roughly $24 the asymmetry becomes compelling enough for Strong Buy if the thesis remains intact
Management and capital allocation

Management deserves credit for identifying Alani Nu and constructing a portfolio that reaches different consumer cohorts. The acquisition has strengthened the strategic position, and the expanded PepsiCo relationship gives CELH distribution capabilities that would have taken years to recreate independently.

Execution on CELSIUS itself is the main weakness. Management cut the assortment aggressively while limiting innovation during a major integration period, and desired shelf and cold-space gains arrived more slowly than the SKU reductions. Management has acknowledged the sequencing problem and is rebuilding the brand's innovation and retail plan for 2027.

The August 10 organizational realignment adds another execution variable. Tyler Bohannon moved from EVP of North American Sales to Chief Commercial Officer, Tony Guilfoyle moved into the newly created Chief Business Transformation Officer role, and President/COO Eric Hanson departed. The changes may sharpen commercial accountability, but they also place more execution responsibility on a reorganized leadership team during an important recovery period.

The PepsiCo structure also lowers the capital-allocation assessment. The partnership is strategically valuable, but preferred dividends, potential dilution, liquidation preference and governance rights make the common-equity economics materially more complex than a normal distribution agreement.

Management Takeaway

Management has demonstrated strong strategic vision and acquisition judgment, but operating execution is not yet as proven as portfolio construction. The 2027 CELSIUS recovery and the effectiveness of the post-Q2 leadership structure are important tests. Capital allocation is acceptable rather than elite because the strategic benefits of PepsiCo come with meaningful preferred-stock and dilution costs.

Latest analyst questions

Analyzed call: Q2 2026 Earnings Call, 2026-08-06 · Research snapshot: 2026-10-21 (comparison refresh; fundamental review preserved from 2026-10-04)

The Q2 2026 earnings call included six analyst participants. All six raised material issues, so the table below covers the complete Q&A roster rather than a selected sample.

Analyst / Firm Core Question Management Response Research Read-Through
Peter Grom / UBS What gives management confidence that CELSIUS performance improves exiting 2026 and into 2027, and what would success look like over the next six to nine months? Management said the CELSIUS base and brand-health metrics remain strong, integration-related underinvestment is behind it, 16-ounce innovation is planned for 2027, retailer planning is progressing, and the company expects the brand to exit 2026 back in growth. The recovery case is internally coherent, but confidence still rests on future innovation, retailer execution and a return to growth that has not yet shown up in reported results
Bonnie Herzog / Goldman Sachs Was the CELSIUS SKU rationalization actually the right decision, what would management do differently, and how much visibility does it have into further Q3 downside? John Fieldly explicitly acknowledged that management went too deep on CELSIUS rationalization and said he would not cut as many SKUs if doing it again. Management expects Q3 weekly run rates to be broadly similar to Q2 with slight improvement while cycling stronger prior-year innovation. This is the most important management admission on the call. It supports the view that part of the weakness was self-inflicted and repairable, but it also lowers confidence in recent execution and makes proof of recovery more important
Kaumil Gajrawala / Jefferies Does “Q3 looks like Q2” refer to dollars or percentage, and how can CELH manage harder Alani Nu comparisons while simultaneously reversing CELSIUS weakness? Management clarified that the Q3 comparison primarily referred to dollar levels, expects CELSIUS pressure to ease into Q4/2027, and argued that Alani Nu can sustain growth by building its permanent base SKU portfolio so LTOs become a smaller portion of total growth over time. The portfolio can work through the comparison problem, but the thesis needs Alani's core business—not just LTO load-ins—to remain strong while CELSIUS recovers
Jim Salera / Stephens How large should the Q4 CELSIUS recovery be, what run rate should investors infer for 2027, should they expect a quick snapback or gradual build, and how quickly can international contribute? Management pointed to easier rationalization comps, additional permanent/cold distribution and 2027 innovation, but explicitly said the recovery should be a slow build, not a direct snapback. International is a meaningful long-term opportunity but remains a small near-term revenue contributor. Do not model a sharp Q4 rescue or rely on international for the near-term thesis. The recovery should be judged through 2027, which increases the importance of patience and execution monitoring
Eric Serotta / Morgan Stanley Why were previously discussed shelf-space gains slower than expected, where do they stand now, and what guardrails will prevent CELSIUS from rebuilding another excessive SKU tail? Management said fixture and cold-space installations took longer and were more labor-intensive than initially expected, although July placements were coming in according to the revised timeline. Going forward, management intends to continually replace low-productivity tail SKUs with productive permanent innovation rather than simply proliferating SKUs. The delay confirms that the original sequencing assumptions were too optimistic. The proposed SKU discipline is sensible, but investors need evidence that CELH can add innovation without recreating the assortment problem it is now fixing
Andrea Teixeira / JPMorgan How should investors think about Alani Nu's Q4 cadence given difficult pipe-fill comparisons, innovation load-ins and distributor-related noise, and when should those distortions disappear? Management said Q4 and Q1 timing depends on how 2027 innovation is sequenced with PepsiCo; that plan was not fully baked at the time of the call. Alani faces a tougher prior-year pipe-fill comp while CELSIUS has an easier comp and new innovation, and management said it would provide more detail after Q3. This exposes genuine forecasting uncertainty in reported revenue. Strong register-level demand remains the key health signal, but quarterly Alani/CELSIUS net-sales comparisons can remain noisy until load-in and DSD sequencing normalize

Analyst-Q&A Takeaway

Taken together, analysts challenged four parts of the story: the credibility and timing of the CELSIUS recovery, whether management caused unnecessary damage through SKU rationalization, whether Alani Nu can carry growth through increasingly difficult comparisons, and whether shelf-space/load-in execution is occurring when management originally expected.

Two management admissions are particularly important. First, management explicitly said it cut too many CELSIUS SKUs and would handle the rationalization differently in hindsight. Second, the exact Q4/Q1 sequencing of Alani Nu and 2027 innovation with PepsiCo was not yet fully determined at the time of the call. Those admissions make the thesis more credible in one sense—management is acknowledging mistakes and uncertainty—but they also reinforce that this is a 2027 execution story rather than a near-term snapback story.

Sources and research notes
Source Type Date / Period What It Supports
Q2 2026 Investor Presentation Company IR presentation 2026-08-06 Portfolio strategy, Q2/Q1 market share, category size, retail sales, international TAM, financial bridges
Q2 2026 Earnings Release Company IR / earnings release Q2 / H1 2026 Revenue, margins, brand revenue, retail trends, brand share, distribution productivity, international growth
Q1 2026 Earnings Release Company IR / earnings release Q1 2026 Prior-period CELSIUS, Alani Nu and Rockstar market shares used for sequential comparison
Q2 2026 Earnings Call Transcript Earnings-call transcript 2026-08-06 Complete six-analyst Q&A, SKU rationalization admission, shelf-space timing, Alani/CELSIUS cadence, distributor/load-in noise and 2027 recovery plan
Q2 2026 Form 10-Q Regulatory filing H1 2026 Financial statements, cash flow, debt, preferred stock, dilution, SBC, customer concentration, accounting detail
FY2025 Form 10-K Regulatory filing FY2023-FY2025 Historical financials, acquisitions, Alani Nu contribution, cash, debt, dilution and capital structure
Leadership Realignment Company IR / corporate update 2026-08-10 Post-Q2 management and organizational changes
Barclays 19th Annual Global Consumer Conference Conference transcript 2026-09-08 Most recent post-earnings commentary on portfolio execution, margins, assortment and growth
CELH Price History Market data 2026-10-02 close $26.75 valuation and score price snapshot
CELH Financial Ratios Market / valuation data 2026-10-02 snapshot Market capitalization, enterprise value, forward P/E, price/sales and price/FCF
CELH Income Statement Financial-data cross-check FY2023-FY2025 Historical revenue, margins and diluted-share cross-checks
CELH Cash Flow Statement Financial-data cross-check FY2023-FY2025 Historical free cash flow and SBC cross-checks
Monster Beverage Q2 2026 Results Direct competitor IR / earnings release Q2 2026 Monster growth, gross margin and operating scale
Monster Beverage Financial Ratios Comparable-company market data 2026-10-02 snapshot Monster forward P/E, price/sales and price/FCF
Red Bull Company Profile Direct competitor company data FY2025 Red Bull global scale, turnover growth, can volume and geographic reach
Red Bull Austrian Company Register Official company registry Current Red Bull GmbH legal form and private ownership structure
PepsiCo Financial Ratios Secondary valuation-anchor market data 2026-10-02 snapshot PepsiCo forward P/E, price/sales and price/FCF
CELH common regular-close snapshot Market data 2026-10-20 16:00 EDT Refreshed price, scenario returns and normalized Opportunity Score / shared rank
SEC XBRL company facts — CELH Regulatory filing (as tagged) FY2026, through 2026-09-30 Current-year standalone-quarter and year-to-date source facts for FCF, SBC, revenue and other reported metrics

Research context

  • Company: Celsius Holdings, Inc.

  • Ticker: CELH

  • Exchange: NASDAQ

  • Sector / Industry: Consumer Staples / Non-Alcoholic Beverages

  • Template version: 2.7

  • Research date: 2026-10-21 (comparison refresh; fundamental review preserved from 2026-10-04)

  • Valuation / score price snapshot: $29.98 — 2026-11-03 regular-session close, America/New_York

  • Tracking tier: Primary Watchlist

  • Owned: Yes

  • Primary operating period reviewed: Q2 2026 and H1 2026

  • Historical period reviewed: FY2023-FY2025 plus H1 2026

  • Latest investor presentation reviewed: Q2 2026 Investor Presentation, 2026-08-06

  • Latest earnings call reviewed: Q2 2026 Earnings Call, 2026-08-06

  • Latest post-earnings management commentary reviewed: Barclays 19th Annual Global Consumer Conference, 2026-09-08

  • Price snapshot date: 2026-11-03

  • Price snapshot time / timezone: Regular-session close, America/New_York (including exchange half-days)

  • Competitor / analyst-Q&A audit: 2026-10-28; original operating, price and valuation snapshots retained.

Full original report

Celsius Holdings (CELH) — Investment Analysis

Company & Research Metadata

  • Company: Celsius Holdings, Inc.

  • Ticker: CELH

  • Exchange: NASDAQ

  • Sector / Industry: Consumer Staples / Non-Alcoholic Beverages

  • Template version: 2.7

  • Research date: 2026-10-21 (comparison refresh; fundamental review preserved from 2026-10-04)

  • Valuation / score price snapshot: $29.98 — 2026-11-03 regular-session close, America/New_York

  • Tracking tier: Primary Watchlist

  • Owned: Yes

  • Primary operating period reviewed: Q2 2026 and H1 2026

  • Historical period reviewed: FY2023-FY2025 plus H1 2026

  • Latest investor presentation reviewed: Q2 2026 Investor Presentation, 2026-08-06

  • Latest earnings call reviewed: Q2 2026 Earnings Call, 2026-08-06

  • Latest post-earnings management commentary reviewed: Barclays 19th Annual Global Consumer Conference, 2026-09-08

  • Price snapshot date: 2026-11-03

  • Price snapshot time / timezone: Regular-session close, America/New_York (including exchange half-days)

  • Competitor / analyst-Q&A audit: 2026-10-28; original operating, price and valuation snapshots retained.

What's Changed Since Previous Review

Current Review: 2026-10-28

Previous Review: 2026-10-21 (comparison refresh; fundamental review preserved from 2026-10-04)

Update Trigger: Competitor relevance and analyst-Q&A correction

Area Previous View Current View Investment Impact
Competition Preceding operating and comparable-company classifications Company-specific rivals reviewed; relevant comparisons retained Corrects the competitive comparison; does not by itself re-underwrite the valuation
Analyst questions Prior source-linked Q&A summaries Complete questions and sentence-form management answers; all 6 existing rows retained Improves readability while preserving the recorded exchange meaning
Valuation and scores Approved operating/price snapshots, scenarios, scores and decisions Preserved No price refresh, rerank or change to valuation assumptions in this correction pass

Thesis: No new fundamental thesis determination is made in this correction pass. The prior investment decision is preserved; the corrected competitive scope should govern the next substantive review.

Investment Snapshot

Metric Current View
Price Snapshot $29.98 — 2026-11-03 regular-session close, America/New_York
Rating / Zone Status Buy
Bear / Base / Bull Fair Value $21.60 / $38.50 / $55.35
Scenario Probabilities 30% / 50% / 20%
Probability-Weighted Fair Value $36.80
Probability-Weighted Expected Return +22.7%
Bear-Case Return -28.0%
Strong Buy Zone ≤ $24.00
Buy Zone >$24.00–$31.00
Avoid Chasing Above > $42.00
Quality Score / Tier 76.1 / Tier B
Opportunity Score / Rank 69.7 / #8 of 76
Risk Level Medium-High
Tracking / Ownership Primary Watchlist / Owned

Decision rationale: At $26.75, CELH is attractive enough to rate Buy, but it is not a low-risk bargain. The valuation no longer requires hypergrowth, while Alani Nu has become a genuine second franchise and the PepsiCo distribution relationship creates meaningful scale. The unresolved issue is whether the original CELSIUS brand can return to sustainable growth while margins normalize. If that happens, current valuation understates normalized earnings power; if CELSIUS weakness proves structural, the discount is justified.

Investment Thesis

CELH has evolved from a fast-growing single-brand company into a three-brand energy platform:

Brand Role Q2 2026 Revenue Current Direction
CELSIUS Fitness, health and performance $387M -11.7% YoY revenue; retail sales -2%
Alani Nu Younger, female-skewed, flavor-led consumer $364M +21% reported revenue; retail +55.7%
Rockstar Traditional/core energy consumer $67M Retail sales -13%
Total Multi-brand portfolio $818M +10.6%

The headline 10.6% growth obscures a very different story underneath it. Alani Nu has become almost as large as CELSIUS and is doing the heavy lifting, while the original brand contracted sharply. Rockstar currently contributes scale but not growth.

The central investment question is whether CELSIUS's weakness is a temporary integration and assortment mistake inside an otherwise healthy brand or evidence that its competitive momentum has structurally weakened. I lean toward temporary but not yet proven. Management has acknowledged that it cut CELSIUS's assortment too aggressively and is rebuilding innovation and shelf presence for 2027, but it is describing the recovery as a gradual build rather than a quick rebound.

Long-term per-share value creation depends on four things: Alani Nu remaining durable, CELSIUS returning to growth, gross margin recovering toward the low-50% range, and the PepsiCo relationship creating more distribution value than the preferred-stock and concentration costs it introduces.

What the Market May Be Mispricing

The market may be underestimating three things.

First, Alani Nu increasingly looks like a second franchise rather than a purchased growth patch. Its Q2 retail sales increased 55.7%, and it held 8.7% of tracked U.S. RTD energy sales.

Second, PepsiCo gives CELH distribution capabilities that would be extremely difficult to recreate organically. The company can approach retailers with three differentiated brands rather than fighting for shelf space one product at a time.

Third, current earnings are being suppressed by integration, promotional intensity and gross-margin pressure. If consolidated growth remains healthy while gross margin recovers, earnings can grow faster than revenue.

The market is right to demand proof from the original CELSIUS brand. Alani Nu cannot indefinitely compensate for a structurally declining flagship.

Business Overview

Celsius Holdings owns three major energy brands with distinct roles. The company develops, markets and sells functional beverages while relying heavily on PepsiCo for North American distribution. The model is relatively asset-light compared with a vertically integrated beverage manufacturer: brand strength, innovation, shelf and cold-space placement, retailer productivity, promotion efficiency and supply-chain execution matter more than owned production capacity.

Segment / Brand / Business Unit Role Revenue / Growth Economics / Position Strategic Takeaway
CELSIUS Fitness-first, zero-sugar functional energy $387M Q2 revenue; -11.7% YoY Largest legacy franchise; productivity per distribution point improved after SKU rationalization Recovery is the most important near-term thesis variable
Alani Nu Flavor-led modern energy with younger/female skew $364M Q2 revenue; +21% reported; retail +55.7% High consumer momentum and expanding distribution Genuine second growth franchise
Rockstar Traditional/core energy $67M Q2 revenue; retail -13% Integrated onto CELH platform; weak current growth Turnaround optionality, not required for base case
International CELSIUS-led expansion with future Alani opportunity $27M Q2 revenue; +10% YoY Small percentage of revenue today Long-duration upside rather than a 2027 valuation pillar

CELSIUS

CELSIUS is the original franchise and remains the foundation of the company. Its positioning around fitness, active lifestyles, zero sugar and functional energy differentiated it from traditional energy drinks and helped broaden the category toward health-conscious consumers.

Management rationalized SKUs while integrating Alani Nu and Rockstar, reducing CELSIUS points of distribution by roughly 7%. Dollars per point of distribution improved about 16% sequentially in Q2, suggesting the remaining assortment became more productive, but that productivity improvement did not offset lost assortment, greater promotional spending, club-channel softness and shipment timing.

Alani Nu

Alani Nu reaches a meaningfully different audience and has a stronger flavor and limited-time-offer culture than the original brand. CELH paid heavily for it, but Alani contributed roughly $1.0 billion of revenue in only nine months of CELH ownership during 2025 and continues to post strong consumer growth.

Rockstar

Rockstar gives CELH access to a traditional energy demographic that neither CELSIUS nor Alani targets as directly. Its current performance does not justify assigning meaningful turnaround value in the base case, which makes successful stabilization incremental upside rather than a required assumption.

Business Takeaway

CELH now makes money through a multi-brand energy platform rather than a single challenger brand. The most important long-term value drivers are CELSIUS brand recovery, Alani Nu durability, portfolio-level distribution productivity and margin normalization. Rockstar and international expansion can add upside, but neither is required to justify the current base case.

Industry, TAM & Market Share

Energy remains an attractive beverage category because consumer adoption is broadening beyond the traditional male energy-drink customer and into more usage occasions, wellness positioning and zero-sugar products. CELH's three-brand architecture is strategically aligned with that broadening market.

Management's Q2 presentation sizes the U.S. energy market at approximately $28.5 billion, with additional meaningful markets in Britain, Australia, France, Canada and other countries. International revenue remains a small portion of CELH today, so most international opportunity has not yet entered the financial base.

Market-Share Analysis

Company / Product / Segment Market Definition Current Share Prior Share Direction Investment Implication
Celsius Holdings portfolio U.S. RTD energy, Circana MULO+ w/C, Q2 2026 20.1% 21.0% Q1 2026 Down 0.9 ppt QoQ Still the clear #3 scaled portfolio, but sequential share softened
Red Bull U.S. RTD energy, Circana MULO+ w/C, Q2 2026 34.4% 34.6% Q1 2026 Down 0.2 ppt QoQ Category leader and most important direct operating competitor
Monster portfolio U.S. RTD energy, Circana MULO+ w/C, Q2 2026 32.2% 32.6% Q1 2026 Down 0.4 ppt QoQ Closest publicly traded direct operating and valuation comparable
CELSIUS brand U.S. RTD energy, Circana MULO+ w/C, Q2 2026 9.5% 9.9% Q1 2026 Down 0.4 ppt QoQ Core brand needs stabilization and renewed distribution
Alani Nu U.S. RTD energy, Circana MULO+ w/C, Q2 2026 8.7% 9.0% Q1 2026 Down 0.3 ppt QoQ Strong YoY retail growth remains the main portfolio growth engine
Rockstar U.S. RTD energy, Circana MULO+ w/C, Q2 2026 1.9% 2.0% Q1 2026 Down 0.1 ppt QoQ Turnaround remains unproven

The portfolio's long-term share gain has been substantial, but much of the jump versus early 2025 is acquisition-driven and should not be interpreted as organic share gain. The key next step is proving that the combined portfolio can grow share organically.

Industry Takeaway

The external market is large and attractive enough to support the thesis. TAM is not the binding constraint; execution is. CELH already has enough U.S. scale to matter materially to retailers and PepsiCo, so future value depends more on organic share productivity, brand health and international execution than on proving that the category is large enough.

Customer Economics

Traditional SaaS-style CAC, retention and lifetime-value metrics are not meaningful for CELH. The useful proxies are retail velocity, repeat demand, points of distribution, dollars per point of distribution, promotional intensity, retailer productivity and the gap between scanner sales and reported net revenue.

Alani Nu currently has the strongest evidence of healthy incremental economics. Its retail growth substantially exceeds reported revenue growth, distribution is broad, and innovation continues to drive trial. For CELSIUS, the improvement in dollars per point of distribution after SKU rationalization is encouraging, but the next test is whether the company can regain shelf and cold-space distribution without requiring excessive promotion.

Moving brands into PepsiCo's direct-store-delivery system increases trade billbacks and allowances, so consumer scanner growth can temporarily look stronger than reported net revenue. That distinction is useful for diagnosing demand, but it cannot excuse weak reported economics indefinitely.

PepsiCo represented 60.2% of Q2 revenue and 59.6% of first-half revenue, which creates exceptional distribution leverage but also unusually high dependency on one commercial partner.

Customer-Economics Takeaway

Incremental growth appears attractive when it is driven by Alani Nu velocity, productive shelf space and repeat demand. The biggest economic question is whether CELH can restore flagship-brand distribution and revenue while reducing promotion and gross-to-net pressure. Strong scanner demand ultimately has to translate into reported revenue, margin and cash earnings.

Competitive Landscape & Moat

Competitive Landscape

Competitor Market Share Positioning Advantages vs. Company Disadvantages vs. Company Current Direction
Red Bull 34.4% Q2 2026 U.S. RTD energy Global premium category leader Brand power, global reach, marketing machine, category leadership and consistency Less diversified modern-energy portfolio by consumer proposition Share down modestly QoQ but remains #1
Monster Beverage 32.2% Q2 2026 U.S. RTD energy portfolio Scaled global energy portfolio Scale, 55.9% Q2 gross margin, international reach, proven execution and public-market discipline CELH has stronger wellness positioning and faster-growing Alani Nu franchise Strong Q2 growth; remains #2
Emerging energy brands Not consistently comparable Trend-driven challengers such as Ghost, C4, Bloom and others Fast trend response, niche authenticity and focused communities Less portfolio scale, distribution leverage and retailer relevance than CELH Fragmented but strategically important

Moat Assessment

CELH does not have a traditional hard moat. Consumers can switch beverages instantly. Its defenses come from brand equity, shelf and cold-space access, PepsiCo distribution, retailer relevance, innovation cadence and scale.

The PepsiCo relationship is the biggest structural advantage. PepsiCo is the primary U.S./Canada distributor for the portfolio and has strategic economic and governance rights. That makes it difficult for smaller brands to match CELH's route-to-market, but the advantage has a real cost: PepsiCo's preferred securities have a combined $1.135 billion liquidation preference, pay a 5% cumulative dividend, and carry significant potential dilution and governance rights.

Moat direction: Stable, with potential to strengthen

Competitive Takeaway

CELH is structurally stronger than most emerging energy brands but remains behind Red Bull and Monster in proven global brand power, margins and operating consistency. Red Bull is the most important direct operating competitor; Monster is both a direct operating competitor and the closest public valuation comparable. CELH's differentiated advantage is its three-brand architecture and PepsiCo distribution, but that advantage only becomes durable if the flagship CELSIUS brand stabilizes.

Financial Profile

Historical Financials

Financial reporting periods follow the issuer's fiscal year: completed FY rows plus standalone current-year quarters and cumulative H1/9M for FY2026. Revenue, FCF and SBC are flows; cash is a period-end balance. FCF = operating cash flow minus property/equipment capex from SEC company facts; quarterly FCF after Q1 and any quarterly SBC derived from YTD are visibly marked. Missing values are N/D, not zero. Unit: USD millions. Data extracted from SEC-tagged filings as of 2026-11-07. Company-specific FCF definitions and acquisition effects may require further reconciliation.

Period Revenue Growth Gross Margin Operating Margin FCF FCF Margin SBC Diluted Shares Cash Debt
FY2023 $1.32B — 48.0% 20.2% $124M 9.4% $21M 237.0M $756M $2M
FY2024 $1.36B 2.9% 50.2% 11.5% $240M 17.7% $20M 237.4M $890M $0M
FY2025 $2.52B 85.5% 50.4% 5.6% $323M 12.9% $28M 254.9M $399M $695M
Q1 FY2026 $782.615 N/D 48.3% 17.8% $65.807 (derived: CFO - capex) 8.4% $7.626 259.764 $549.201 N/D
Q2 FY2026 $817.925 N/D 48.1% 9.2% $205.477 (derived: current YTD - prior YTD) 25.1% $10.565 (derived: current YTD - prior YTD) 256.933 $631.234 N/D
H1 FY2026 $1,600.54 N/D 48.2% 13.4% $271.284 (derived: CFO - capex) 16.9% $18.191 258.495 $631.234 N/D
Q3 FY2026 $847.228 N/D 46.8% 20.3% $127.692 (derived: current YTD - prior YTD) 15.1% $8.714 (derived: current YTD - prior YTD) 254.912 $700.617 N/D
9M FY2026 $2,447.768 N/D 47.7% 15.8% $398.976 (derived: CFO - capex) 16.3% $26.905 257.269 $700.617 N/D

Supplemental historical reporting context (retained)

Supplemental historical reporting context (retained)

Supplemental historical reporting context (retained)

2025's enormous revenue growth was primarily acquisition-driven, while GAAP operating margin was distorted by large distributor-termination and integration-related costs. Free cash flow is more informative about the underlying economics: the business remains relatively capital-light and cash-generative.

Gross margin is the clearest near-term financial pressure point. Q2 gross margin fell to 48.1% from 51.5%. A return through 50% would create meaningful earnings leverage without requiring extraordinary top-line growth.

At June 30 CELH had roughly $631 million of cash and $675 million of debt, so conventional net debt is modest. That headline understates the economic capital burden because PepsiCo's preferred securities sit above common shareholders and generate roughly $57 million of annual preferred dividends at the current liquidation preference.

Financial Takeaways

  • Organic growth is materially weaker than headline consolidated growth because acquisitions and distribution transitions dominate the comparison.
  • Gross-margin recovery is a major source of potential earnings leverage.
  • Free cash flow remains a meaningful strength and supports integration, reinvestment and buybacks.
  • Conventional leverage is manageable, but preferred securities materially complicate the capital structure and potential dilution.
  • Per-share value creation depends on converting portfolio scale into organic growth and normalized margins rather than merely maintaining acquired revenue.

Financial direction: Mixed, but underlying cash economics remain healthy.

Management & Capital Allocation

Management deserves credit for identifying Alani Nu and constructing a portfolio that reaches different consumer cohorts. The acquisition has strengthened the strategic position, and the expanded PepsiCo relationship gives CELH distribution capabilities that would have taken years to recreate independently.

Execution on CELSIUS itself is the main weakness. Management cut the assortment aggressively while limiting innovation during a major integration period, and desired shelf and cold-space gains arrived more slowly than the SKU reductions. Management has acknowledged the sequencing problem and is rebuilding the brand's innovation and retail plan for 2027.

The August 10 organizational realignment adds another execution variable. Tyler Bohannon moved from EVP of North American Sales to Chief Commercial Officer, Tony Guilfoyle moved into the newly created Chief Business Transformation Officer role, and President/COO Eric Hanson departed. The changes may sharpen commercial accountability, but they also place more execution responsibility on a reorganized leadership team during an important recovery period.

The PepsiCo structure also lowers the capital-allocation assessment. The partnership is strategically valuable, but preferred dividends, potential dilution, liquidation preference and governance rights make the common-equity economics materially more complex than a normal distribution agreement.

Management Takeaway

Management has demonstrated strong strategic vision and acquisition judgment, but operating execution is not yet as proven as portfolio construction. The 2027 CELSIUS recovery and the effectiveness of the post-Q2 leadership structure are important tests. Capital allocation is acceptable rather than elite because the strategic benefits of PepsiCo come with meaningful preferred-stock and dilution costs.

Valuation

Current Valuation

Metric Value
Price Snapshot $29.98 — 2026-11-03 regular-session close, America/New_York
Market Capitalization ~$6.77B
Enterprise Value ~$6.81B
Forward P/E ~19.9×
Price / Sales ~2.2×
Price / FCF ~14.6×

At the current price, CELH has lost most of the premium historically attached to its growth story. The valuation now prices the company much closer to a normal consumer-growth business while still applying some premium to mature beverage companies.

Only the price row is refreshed here. Other quoted valuation statistics retain their earlier source dates and definitions.

Comparable Company Analysis

Company Relevance Public / Private Forward P/E Price / Sales Price / FCF Growth / Margin / Risk Context
Celsius Holdings Subject company Public 19.9× 2.2× 14.6× Q2 revenue +10.6%; 48.1% gross margin; higher integration and flagship-brand execution risk
Monster Beverage Primary direct operating and public valuation comparable Public 34.9× 9.1× 40.1× Q2 revenue +20.2%; 55.9% gross margin; much larger international scale and stronger operating consistency
Red Bull Primary direct operating comparable Private N/A — private N/A — private N/A — private 2025 group turnover €12.196B (+8.6%), 13.969B cans sold, 178-country presence; no public-market multiple
PepsiCo Secondary mature-beverage valuation and strategic-distribution anchor Public 14.5× 1.8× 18.5× Much more diversified, lower-growth and lower-risk; useful as a mature beverage floor, not a direct energy pure-play

Comparable takeaway: Red Bull and Monster are the economically relevant direct competitors. Monster is the only close publicly traded valuation comparable; Red Bull is private and therefore should remain visible with market multiples marked unavailable rather than being replaced by a less-relevant public company. PepsiCo is useful only as a secondary mature-beverage valuation anchor. A mechanical peer average across these companies would be misleading.

Valuation Scenarios

My primary framework uses normalized 2027 adjusted EPS because near-term GAAP earnings remain distorted by integration and distributor-related accounting.

Scenario Key Assumptions 2027 EPS Multiple Fair Value Probability Probability Rationale Return From Price Snapshot
Bear CELSIUS remains weak; Alani slows; margins remain high-40s $1.35 16× $21.60 30% Material risk that core-brand weakness is more structural and portfolio synergies take longer -28.0%
Base CELSIUS returns to modest growth; Alani remains strong; gross margin approaches ~50%+ $1.75 22× $38.50 50% Most likely if 2026 disruption proves temporary but recovery is gradual +28.4%
Bull CELSIUS recovery + Alani durability + international contribution + margin normalization $2.05 27× $55.35 20% Requires cleaner execution and faster proof of portfolio leverage +84.6%
Probability-Weighted 30% Bear / 50% Base / 20% Bull — — $36.80 100% Weighted scenario outcome +22.7%

The 22× base multiple represents a substantial discount to Monster while recognizing that CELH deserves more than a mature-beverage multiple if its portfolio can sustain growth. The bull case still uses a multiple materially below Monster's current valuation.

The bear case is what makes the current setup attractive. CELH does not need to regain its former premium valuation for $26.75 to work. Modeled downside is about 19% in the bear case, versus roughly 38% probability-weighted expected upside.

Valuation Takeaway

  • Primary valuation method: Normalized 2027 adjusted EPS scenario analysis
  • Cross-check methods: Forward P/E, price/sales, price/FCF and public-market comparison primarily against Monster, with PepsiCo as a secondary mature-beverage anchor
  • Key valuation dependencies: CELSIUS returning to growth, Alani Nu remaining durable, gross margin recovering and PepsiCo economics not becoming a larger drag
  • Valuation confidence / Risk Level: Medium-High risk with moderate valuation confidence
  • Margin-of-safety conclusion: The current price provides enough expected upside relative to modeled bear-case downside for a Buy; below roughly $24 the asymmetry becomes compelling enough for Strong Buy if the thesis remains intact

Analyst Questions

The Q2 2026 earnings call included six analyst participants. All six raised material issues, so the table below covers the complete Q&A roster rather than a selected sample.

Analyst / Firm Core Question Management Response Research Read-Through
Peter Grom / UBS What gives management confidence that CELSIUS performance improves exiting 2026 and into 2027, and what would success look like over the next six to nine months? Management said the CELSIUS base and brand-health metrics remain strong, integration-related underinvestment is behind it, 16-ounce innovation is planned for 2027, retailer planning is progressing, and the company expects the brand to exit 2026 back in growth. The recovery case is internally coherent, but confidence still rests on future innovation, retailer execution and a return to growth that has not yet shown up in reported results
Bonnie Herzog / Goldman Sachs Was the CELSIUS SKU rationalization actually the right decision, what would management do differently, and how much visibility does it have into further Q3 downside? John Fieldly explicitly acknowledged that management went too deep on CELSIUS rationalization and said he would not cut as many SKUs if doing it again. Management expects Q3 weekly run rates to be broadly similar to Q2 with slight improvement while cycling stronger prior-year innovation. This is the most important management admission on the call. It supports the view that part of the weakness was self-inflicted and repairable, but it also lowers confidence in recent execution and makes proof of recovery more important
Kaumil Gajrawala / Jefferies Does “Q3 looks like Q2” refer to dollars or percentage, and how can CELH manage harder Alani Nu comparisons while simultaneously reversing CELSIUS weakness? Management clarified that the Q3 comparison primarily referred to dollar levels, expects CELSIUS pressure to ease into Q4/2027, and argued that Alani Nu can sustain growth by building its permanent base SKU portfolio so LTOs become a smaller portion of total growth over time. The portfolio can work through the comparison problem, but the thesis needs Alani's core business—not just LTO load-ins—to remain strong while CELSIUS recovers
Jim Salera / Stephens How large should the Q4 CELSIUS recovery be, what run rate should investors infer for 2027, should they expect a quick snapback or gradual build, and how quickly can international contribute? Management pointed to easier rationalization comps, additional permanent/cold distribution and 2027 innovation, but explicitly said the recovery should be a slow build, not a direct snapback. International is a meaningful long-term opportunity but remains a small near-term revenue contributor. Do not model a sharp Q4 rescue or rely on international for the near-term thesis. The recovery should be judged through 2027, which increases the importance of patience and execution monitoring
Eric Serotta / Morgan Stanley Why were previously discussed shelf-space gains slower than expected, where do they stand now, and what guardrails will prevent CELSIUS from rebuilding another excessive SKU tail? Management said fixture and cold-space installations took longer and were more labor-intensive than initially expected, although July placements were coming in according to the revised timeline. Going forward, management intends to continually replace low-productivity tail SKUs with productive permanent innovation rather than simply proliferating SKUs. The delay confirms that the original sequencing assumptions were too optimistic. The proposed SKU discipline is sensible, but investors need evidence that CELH can add innovation without recreating the assortment problem it is now fixing
Andrea Teixeira / JPMorgan How should investors think about Alani Nu's Q4 cadence given difficult pipe-fill comparisons, innovation load-ins and distributor-related noise, and when should those distortions disappear? Management said Q4 and Q1 timing depends on how 2027 innovation is sequenced with PepsiCo; that plan was not fully baked at the time of the call. Alani faces a tougher prior-year pipe-fill comp while CELSIUS has an easier comp and new innovation, and management said it would provide more detail after Q3. This exposes genuine forecasting uncertainty in reported revenue. Strong register-level demand remains the key health signal, but quarterly Alani/CELSIUS net-sales comparisons can remain noisy until load-in and DSD sequencing normalize

Analyst-Q&A Takeaway

Taken together, analysts challenged four parts of the story: the credibility and timing of the CELSIUS recovery, whether management caused unnecessary damage through SKU rationalization, whether Alani Nu can carry growth through increasingly difficult comparisons, and whether shelf-space/load-in execution is occurring when management originally expected.

Two management admissions are particularly important. First, management explicitly said it cut too many CELSIUS SKUs and would handle the rationalization differently in hindsight. Second, the exact Q4/Q1 sequencing of Alani Nu and 2027 innovation with PepsiCo was not yet fully determined at the time of the call. Those admissions make the thesis more credible in one sense—management is acknowledging mistakes and uncertainty—but they also reinforce that this is a 2027 execution story rather than a near-term snapback story.

Thesis Monitoring

Driver Current State Positive Trigger / Catalyst Negative Trigger / Falsifier What It Changes
CELSIUS brand Q2 revenue -11.7%; retail sales -2%; share 9.5% vs. 9.9% Q1 Returns to positive retail and net-revenue growth with productive shelf gains Remains meaningfully negative through H1 2027 despite restored innovation and distribution Thesis, Quality Score and base/bull valuation lower
Alani Nu Q2 retail +55.7%; share 8.7% vs. 9.0% Q1 Sustains strong core velocity as DSD comparisons normalize Sharp growth deceleration, weak repeat behavior or heavy LTO dependence Growth runway and valuation lower
Gross margin 48.1% Q2; 48.2% H1 Recovers toward 50%-52% as integration, freight and RGM improve Remains below roughly 48%-49% despite normalization Earnings power and fair value lower
PepsiCo execution Strategic distributor, major customer and preferred holder Better shelf/cold placement, service levels and revenue-growth management Persistent service issues, unfavorable economics or incentive conflict Moat and valuation confidence lower
Rockstar Retail sales -13%; 1.9% share Stabilizes and improves velocity Continued sustained decline or larger portfolio drag Mostly removes optional upside unless drag expands
International Small revenue base CELSIUS and Alani establish repeatable growth in priority markets Expansion remains immaterial or destroys margin Long-term growth runway lower
Leadership execution Post-Q2 commercial and transformation realignment Clear accountability and improved retail execution Continued execution slippage or disruptive turnover Management score and confidence lower
Capital structure Strong FCF but complex preferred securities Cash generation and repurchases offset dilution and dividend burden Additional aggressive M&A, higher dilution or worsening preferred economics Per-share value and management score lower

The next quarter should be judged far more on CELSIUS retail trajectory, Alani's underlying growth after distribution effects, gross margin and the 2027 innovation/shelf plan than on whether consolidated revenue beats consensus by a few million dollars.

Quality & Opportunity Scorecards

Quality Score

Component Score Weight Weighted Contribution Evidence
Business durability and economics 76 25% 19.0 Attractive energy category, strong cash generation and multi-brand portfolio, offset by volatile consumer demand and promotion
Moat and competitive position 73 25% 18.3 Brand equity, PepsiCo distribution and retailer scale; limited switching costs and stronger leaders in Red Bull/Monster
Growth runway and durability 84 20% 16.8 Alani Nu, category expansion, international whitespace and broader portfolio
Financial quality and balance sheet 78 15% 11.7 Strong FCF and manageable conventional leverage; margin pressure and preferred-stock complexity
Management, governance and capital allocation 69 15% 10.4 Strong strategic moves and Alani acquisition; CELSIUS execution error, leadership transition and Pepsi preferred economics
Quality Score 76.1 100% 76.1 Tier B
  • Quality Tier: B
  • Speculative override: None

CELH does not reach Tier A because consumer beverages have modest switching costs, CELSIUS is currently contracting, PepsiCo concentration is exceptionally high, and the preferred structure creates governance and dilution complexity. Brand strength, cash generation, category runway, Alani Nu's success and PepsiCo distribution keep overall quality comfortably above average.

Opportunity Score

Component Raw Input Normalized Score Weight Weighted Contribution
Quality 76.1 76.1 30% 22.8
Probability-weighted upside +22.7% 95.5 35% 33.4
Bear-case downside -28.0% 22.0 20% 4.4
Risk / valuation confidence 60 60.0 15% 9.0
Opportunity Score 69.7 100% 69.7
  • Opportunity Rank: #8 of 76
  • Zone Status: Buy

Portfolio Context

  • Tracking tier: Primary Watchlist
  • Owned: Yes
  • Tracking source of truth: my_watchlist.md
  • Portfolio source of truth: portfolio/holdings.md
  • Scoring independence: Ownership, account, share count, position size and cost basis do not alter Quality Score, Opportunity Score, rank, rating, valuation or valuation zones

Investment Decision History

Timestamp Price Rating Zone Status Buy Zone Strong Buy Zone Avoid Chasing Above Base FV P/W FV P/W Return Quality Opportunity / Rank Change / Rationale
2026-10-04 $26.75 Buy Buy $24–$31 ≤ $24 > $42 $38.50 $36.80 +37.6% 76.1 73.0 / Pending Initial fresh analysis under template v2.2; no prior company file used
2026-10-21 (America/New_York) $29.96 Buy Buy >$24.00–$31.00 ≤ $24.00 > $42.00 $38.50 $36.80 +22.8% 76.1 69.7 / #5 Common close and shared-universe rank; prior fundamental assumptions and zones preserved

Material Sources

Source Type Date / Period What It Supports
Q2 2026 Investor Presentation Company IR presentation 2026-08-06 Portfolio strategy, Q2/Q1 market share, category size, retail sales, international TAM, financial bridges
Q2 2026 Earnings Release Company IR / earnings release Q2 / H1 2026 Revenue, margins, brand revenue, retail trends, brand share, distribution productivity, international growth
Q1 2026 Earnings Release Company IR / earnings release Q1 2026 Prior-period CELSIUS, Alani Nu and Rockstar market shares used for sequential comparison
Q2 2026 Earnings Call Transcript Earnings-call transcript 2026-08-06 Complete six-analyst Q&A, SKU rationalization admission, shelf-space timing, Alani/CELSIUS cadence, distributor/load-in noise and 2027 recovery plan
Q2 2026 Form 10-Q Regulatory filing H1 2026 Financial statements, cash flow, debt, preferred stock, dilution, SBC, customer concentration, accounting detail
FY2025 Form 10-K Regulatory filing FY2023-FY2025 Historical financials, acquisitions, Alani Nu contribution, cash, debt, dilution and capital structure
Leadership Realignment Company IR / corporate update 2026-08-10 Post-Q2 management and organizational changes
Barclays 19th Annual Global Consumer Conference Conference transcript 2026-09-08 Most recent post-earnings commentary on portfolio execution, margins, assortment and growth
CELH Price History Market data 2026-10-02 close $26.75 valuation and score price snapshot
CELH Financial Ratios Market / valuation data 2026-10-02 snapshot Market capitalization, enterprise value, forward P/E, price/sales and price/FCF
CELH Income Statement Financial-data cross-check FY2023-FY2025 Historical revenue, margins and diluted-share cross-checks
CELH Cash Flow Statement Financial-data cross-check FY2023-FY2025 Historical free cash flow and SBC cross-checks
Monster Beverage Q2 2026 Results Direct competitor IR / earnings release Q2 2026 Monster growth, gross margin and operating scale
Monster Beverage Financial Ratios Comparable-company market data 2026-10-02 snapshot Monster forward P/E, price/sales and price/FCF
Red Bull Company Profile Direct competitor company data FY2025 Red Bull global scale, turnover growth, can volume and geographic reach
Red Bull Austrian Company Register Official company registry Current Red Bull GmbH legal form and private ownership structure
PepsiCo Financial Ratios Secondary valuation-anchor market data 2026-10-02 snapshot PepsiCo forward P/E, price/sales and price/FCF
CELH common regular-close snapshot Market data 2026-10-20 16:00 EDT Refreshed price, scenario returns and normalized Opportunity Score / shared rank
SEC XBRL company facts — CELH Regulatory filing (as tagged) FY2026, through 2026-09-30 Current-year standalone-quarter and year-to-date source facts for FCF, SBC, revenue and other reported metrics

This page presents the saved CELH analysis. Ratings, zones, and opportunity scores shown above are recalculated at its dated reference price using FolioFacts rules; the live Creator Watchlist uses current market prices and can differ. Missing financial data is not estimated.

Edit company

Prices are entered manually. Changing this company's price updates all your positions in it and the valuation calculations in your private Watchlist and Insights. Shares and average cost stay specific to each position.

COMPANY ANALYSIS

Included accounts

PORTFOLIO EXPORT

Export holdings

Company Overrides

Your estimates, applied across your portfolio and watchlist. These companies have saved research overrides.

How to configure overrides
  1. In Watchlist, find the company and select Edit. Add it first if needed.
  2. Check its investment type, price and price date in Company details.
  3. Open Research overrides to enter fair value, quality, price zones or scenarios, then select Save changes.

Leave fields blank to use available report values. Add your thesis or sources in Notes.

YOUR EXPERIENCE MATTERS

Help improve FolioFacts.

Found a problem or have an idea? Tell us what would make FolioFacts more useful to you.

Please leave out account numbers, balances and other sensitive information. Feedback is private to the site administrator and kept for up to 90 days. Privacy policy